RAPT Therapeutics (RAPT) Shares Issued: 2020-2024
Historic Shares Issued for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to $142.3 million.
- Therapeutics' Shares Issued rose 30965.94% to $142.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $143.5 million, marking a year-over-year increase of 9817.62%. This contributed to the annual value of $143.1 million for FY2024, which is 9785.97% up from last year.
- As of Q4 2024, Therapeutics' Shares Issued stood at $142.3 million, which was up 20,197.00% from $701,000 recorded in Q2 2024.
- Therapeutics' 5-year Shares Issued high stood at $142.3 million for Q4 2024, and its period low was -$132.6 million during Q4 2021.
- For the 3-year period, Therapeutics' Shares Issued averaged around $14.6 million, with its median value being $295,000 (2022).
- Per our database at Business Quant, Therapeutics' Shares Issued slumped by 11,119.12% in 2021 and then soared by 30,965.94% in 2024.
- Therapeutics' Shares Issued (Quarterly) stood at $1.2 million in 2020, then plummeted by 11,119.12% to -$132.6 million in 2021, then surged by 63.49% to -$48.4 million in 2022, then surged by 100.95% to $458,000 in 2023, then surged by 30,965.94% to $142.3 million in 2024.
- Its last three reported values are $142.3 million in Q4 2024, $701,000 for Q2 2024, and $67,000 during Q1 2024.